Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection
- PMID: 22099610
- DOI: 10.1016/j.eururo.2011.11.008
Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection
Abstract
Background: Computed tomography (CT) is a commonly used noninvasive procedure for prostate cancer (PCa) staging. All previous studies addressing the ability of CT scan to predict lymph node invasion (LNI) were based on historical patients treated with limited pelvic lymph node dissection (PLND).
Objective: Assess the value of CT in predicting LNI in contemporary PCa patients treated with extended PLND (ePLND).
Design, setting, and participants: We evaluated 1541 patients undergoing radical prostatectomy and ePLND between 2003 and 2010 at a single center. All patients were preoperatively staged using abdominopelvic CT scan. All lymph nodes with a short axis diameter ≥ 10 mm were considered suspicious for metastatic involvement.
Intervention: All patients underwent preoperative CT scan, radical retropubic prostatectomy, and ePLND, regardless of PCa features at diagnosis.
Measurements: The performance characteristics of CT scan were tested in the overall patient population, as well as according to the National Comprehensive Cancer Network (NCCN) classification and according to the risk of LNI derived from a nomogram developed on an ePLND series. Logistic regression models tested the relationship between CT scan findings and LNI. Discrimination accuracy was quantified with the area under the curve.
Results and limitations: Overall, a CT scan that suggested LNI was found in 73 patients (4.7%). Of them, only 24 patients (32.8%) had histologically proven LNI at ePLND. Overall, sensitivity, specificity, and accuracy of CT scan were 13%, 96.0%, and 54.6%, respectively. In patients with low-, intermediate-, or high-risk PCa according to NCCN classification, sensitivity was 8.3%, 96.3%, and 52.3%, respectively; specificity was 3.6%, 97.3%, and 50.5%, respectively; and accuracy was 17.9%, 94.3%, and 56.1%, respectively. Similarly, in patients with a nomogram-derived LNI risk ≥ 50%, sensitivity, specificity, and accuracy were only 23.9%, 94.7%, and 59.3%, respectively. At multivariable analyses, inclusion of CT scan findings did not improve the accuracy of LNI prediction (81.4% compared with 81.3%; p=0.8). Lack of a central scan review represents the main limitation of our study.
Conclusions: In contemporary patients with PCa, the accuracy of CT scan as a preoperative nodal-staging procedure is poor, even in patients with high LNI risk. Therefore, the need for and the extent of PLND should not be based on the results obtained by CT scan.
Copyright © 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Comment in
-
Nodal staging in prostate cancer: still an unresolved issue.Eur Urol. 2012 Jun;61(6):1139-41. doi: 10.1016/j.eururo.2011.12.044. Epub 2011 Dec 28. Eur Urol. 2012. PMID: 22209377 No abstract available.
Similar articles
-
External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.Urol Int. 2013;90(3):277-82. doi: 10.1159/000343993. Epub 2012 Dec 22. Urol Int. 2013. PMID: 23296120
-
Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.Eur Urol. 2012 Mar;61(3):480-7. doi: 10.1016/j.eururo.2011.10.044. Epub 2011 Nov 7. Eur Urol. 2012. PMID: 22078338
-
Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.Eur Urol. 2017 Oct;72(4):632-640. doi: 10.1016/j.eururo.2017.03.049. Epub 2017 Apr 12. Eur Urol. 2017. PMID: 28412062
-
Pelvic lymph node dissection in prostate cancer.Eur Urol. 2009 Jun;55(6):1251-65. doi: 10.1016/j.eururo.2009.03.012. Epub 2009 Mar 10. Eur Urol. 2009. PMID: 19297079
-
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard.Eur Urol Oncol. 2022 Feb;5(1):1-17. doi: 10.1016/j.euo.2021.08.001. Epub 2021 Sep 17. Eur Urol Oncol. 2022. PMID: 34538770
Cited by
-
Prediction of pelvic lymph node metastases and PSMA PET positive pelvic lymph nodes with multiparametric MRI and clinical information in primary staging of prostate cancer.Eur J Radiol Open. 2023 Mar 30;10:100487. doi: 10.1016/j.ejro.2023.100487. eCollection 2023. Eur J Radiol Open. 2023. PMID: 37065611 Free PMC article.
-
Current and potential future role of PSMA-PET in patients with castration-resistant prostate cancer.World J Urol. 2019 Mar;37(3):457-467. doi: 10.1007/s00345-018-2408-2. Epub 2018 Jul 20. World J Urol. 2019. PMID: 30030659 Review.
-
Diagnostic accuracy of F18 flucholine PET/CT for preoperative lymph node staging in newly diagnosed prostate cancer patients; a systematic review and meta-analysis.Br J Radiol. 2019 Sep;92(1101):20190193. doi: 10.1259/bjr.20190193. Epub 2019 Jul 5. Br J Radiol. 2019. PMID: 31265330 Free PMC article.
-
Eliminating microscopic lymph node metastasis by performing pelvic lymph node dissection during radical prostatectomy for prostate cancer.Mol Clin Oncol. 2020 Feb;12(2):104-110. doi: 10.3892/mco.2019.1965. Epub 2019 Dec 13. Mol Clin Oncol. 2020. PMID: 31929879 Free PMC article.
-
Traditional and novel imaging modalities for advanced prostate cancer: A critical review.Urol Ann. 2023 Jul-Sep;15(3):249-255. doi: 10.4103/UA.UA_170_20. Epub 2023 Jul 17. Urol Ann. 2023. PMID: 37664103 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical